Codix Pharma is focused on providing first class diagnostics and therapeutics in the area of Cardio-metabolic care (Diabetes, Hypertension and Heart Disease). Codix remains steadfast to its mission of—improving the health of the nation, to bring about an effective management & control of diabetes, hypertension and heart disease which is a growing concern world-wide.
In Nigeria, about 5 million people are still living with diabetes, while more than 1.56 million cases of diabetes were recorded in 2015 (IDF). Also, 40,815 deaths in adults due to diabetes were recorded. There is probably an un-diagnosed diabetic patient for every known diagnosed diabetic patient.
For patient population of Non-communicable diseases in developing countries, there is a projected increase of 170% cases. More than 9 million deaths of these cases occur before the age of 60 and could have largely been prevented. Premature deaths from NCDs range from 22% among men and 35% among women in low-income countries to 8% among men and 10% among women in high-income countries.
Early diagnosis is extremely important for patients with non-communicable diseases, and we strive to introduce point-of-care medical devices and rapid diagnostic test kits (RDTs) for efficiency and speed of diagnosis. Patient education, Innovation and commercial efforts are at the heart of our ability to deliver therapies.
Our positive impact on people and the environment continues to grow as we ensure that we contribute to the social and economic progress of all communities in which we operate giving back and putting smiles on their faces.
One major highlight in Codix’s work culture is how we are consistently driven by our vision. The passion, hard work and dedication that our employees bring to work every day is a testament to the inspiration our vision provides and the knowledge of the impact we can make in their lives.